Literature DB >> 17260130

Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children.

Corsino Rey1, Marta Los Arcos, Andrés Concha, Alberto Medina, Soledad Prieto, Pablo Martinez, Belen Prieto.   

Abstract

OBJECTIVES: To analyse the clinical value of procalcitonin (PCT), C-reactive protein (CRP) and leucocyte count in the diagnosis of paediatric sepsis and in the stratification of patients according to severity.
DESIGN: Prospective, observational study.
SETTING: Paediatric intensive care unit (PICU). PATIENTS: Ninety-four children. MEASUREMENT AND
RESULTS: Leucocyte count, PCT and CRP were measured when considered necessary during the PICU stay. Patients were classified, when PCT and CRP were measured, into one of six categories (negative, SIRS, localized infection, sepsis, severe sepsis, and septic shock) according to the definitions of the American College of Chest Physicians /Society of Critical Care Medicine. A total of 359 patient day episodes were obtained. Leucocyte count did not differ across the six diagnostic classes considered. Median plasma PCT concentrations were 0.17, 0.43, 0.79, 1.80, 15.40 and 19.13 ng/ml in negative, systemic inflammatory response syndrome (SIRS), localized infection, sepsis, severe sepsis, and septic shock groups, respectively, whereas median plasma CRP concentrations were 1.35, 3.80, 6.45, 5.70, 7.60 and 16.2 mg/dl, respectively. The area under the ROC curve for the diagnosis of septic patients was 0.532 for leucocyte count (95% CI, 0.462-0.602), 0.750 for CRP (95% CI, 0.699-0.802) and 0.912 for PCT (95% CI, 0.882-0.943). We obtained four groups using CRP values and five groups using PCT values that classified a significant percentage of patients according to the severity of the different SIRS groups.
CONCLUSIONS: PCT is a better diagnostic marker of sepsis in critically ill children than CRP. The CRP, and especially PCT, may become a helpful clinical tool to stratify patients with SIRS according to disease severity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17260130     DOI: 10.1007/s00134-006-0509-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  30 in total

1.  Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit.

Authors:  B Müller; K L Becker; H Schächinger; P R Rickenbacher; P R Huber; W Zimmerli; R Ritz
Journal:  Crit Care Med       Date:  2000-04       Impact factor: 7.598

2.  Sepsis, severe sepsis and septic shock in paediatric multiple organ dysfunction syndrome.

Authors:  A Goh; L Lum
Journal:  J Paediatr Child Health       Date:  1999-10       Impact factor: 1.954

Review 3.  Pathogenetic mechanisms of septic shock.

Authors:  J E Parrillo
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

4.  Sepsis terminology in pediatrics.

Authors:  W R Hayden
Journal:  J Pediatr       Date:  1994-04       Impact factor: 4.406

5.  Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis.

Authors:  S Harbarth; K Holeckova; C Froidevaux; D Pittet; B Ricou; G E Grau; L Vadas; J Pugin
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

6.  Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis.

Authors:  G P Castelli; C Pognani; M Cita; A Stuani; L Sgarbi; R Paladini
Journal:  Minerva Anestesiol       Date:  2006 Jan-Feb       Impact factor: 3.051

7.  Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children.

Authors:  A Enguix; C Rey; A Concha; A Medina; D Coto; M A Diéguez
Journal:  Intensive Care Med       Date:  2001-01       Impact factor: 17.440

8.  C-reactive protein as an indicator of sepsis.

Authors:  P Póvoa; E Almeida; P Moreira; A Fernandes; R Mealha; A Aragão; H Sabino
Journal:  Intensive Care Med       Date:  1998-10       Impact factor: 17.440

9.  Serum procalcitonin in children with suspected sepsis: a comparison with C-reactive protein and neutrophil count.

Authors:  Juan Casado-Flores; Alfredo Blanco-Quirós; Julia Asensio; Eduardo Arranz; Jose A Garrote; Monserrat Nieto
Journal:  Pediatr Crit Care Med       Date:  2003-04       Impact factor: 3.624

10.  Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

View more
  42 in total

1.  C-Reactive Protein and Ferritin Are Associated With Organ Dysfunction and Mortality in Hospitalized Children.

Authors:  Christopher M Horvat; Jamie Bell; Sajel Kantawala; Alicia K Au; Robert S B Clark; Joseph A Carcillo
Journal:  Clin Pediatr (Phila)       Date:  2019-03-31       Impact factor: 1.168

Review 2.  Year in review in Intensive Care Medicine, 2007. III. Ethics and legislation, health services research, pharmacology and toxicology, nutrition and paediatrics.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Johan Groeneveld; Goran Hedenstierna; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Philipp Metnitz; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2008-02-29       Impact factor: 17.440

3.  Prognostic markers for pediatric septic shock: which ones, when, and how?

Authors:  Corsino Rey; James D Fortenberry
Journal:  Intensive Care Med       Date:  2013-07-31       Impact factor: 17.440

Review 4.  Biomarker discovery and development in pediatric critical care medicine.

Authors:  Jennifer M Kaplan; Hector R Wong
Journal:  Pediatr Crit Care Med       Date:  2011-03       Impact factor: 3.624

5.  Fresh frozen plasma prime and the level of gammaglobulin after pediatric cardiopulmonary bypass.

Authors:  Reza Shabanian; Alireza Dehestani; Minoo Dadkhah; Aliyeh Nikdoost; Parvin Akbari Asbagh; Hassan Radmehr; Mitra Rahimzadeh; Soroush Oveisi; Nima Rezaei; Manizheh Ahani; Mohammad Ali Navabi
Journal:  Am J Clin Exp Immunol       Date:  2020-12-15

Review 6.  Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?

Authors:  Dubravka Kojic; Benedikt H Siegler; Florian Uhle; Christoph Lichtenstern; Peter P Nawroth; Markus A Weigand; Stefan Hofer; Thorsten Brenner
Journal:  World J Exp Med       Date:  2015-05-20

7.  Cerebrospinal fluid procalcitonin as a biomarker of bacterial meningitis in neonates.

Authors:  Z Reshi; M Nazir; W Wani; M Malik; J Iqbal; S Wajid
Journal:  J Perinatol       Date:  2017-05-25       Impact factor: 2.521

Review 8.  Emerging infection and sepsis biomarkers: will they change current therapies?

Authors:  Lauren Jacobs; Hector R Wong
Journal:  Expert Rev Anti Infect Ther       Date:  2016-08-17       Impact factor: 5.091

9.  Value of Procalcitonin Measurement for Early Evidence of Severe Bacterial Infections in the Pediatric Intensive Care Unit.

Authors:  Andrew J Lautz; Adam C Dziorny; Adam R Denson; Kathleen A O'Connor; Marianne R Chilutti; Rachael K Ross; Jeffrey S Gerber; Scott L Weiss
Journal:  J Pediatr       Date:  2016-08-29       Impact factor: 4.406

Review 10.  Biomarkers for pediatric sepsis and septic shock.

Authors:  Stephen W Standage; Hector R Wong
Journal:  Expert Rev Anti Infect Ther       Date:  2011-01       Impact factor: 5.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.